- Home
- RYTM vs MKSI Comparison
RYTM vs MKSI Comparison
Compare RYTM & MKSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- MKSI
- Stock Information
- Founded
- RYTM 2008
- MKSI 1961
- Country
- RYTM United States
- MKSI United States
- Employees
- RYTM N/A
- MKSI N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- MKSI Industrial Machinery/Components
- Sector
- RYTM Health Care
- MKSI Industrials
- Exchange
- RYTM Nasdaq
- MKSI Nasdaq
- Market Cap
- RYTM 6.4B
- MKSI 7.1B
- IPO Year
- RYTM 2017
- MKSI 1999
- Fundamental
- Price
- RYTM $110.20
- MKSI $136.68
- Analyst Decision
- RYTM Strong Buy
- MKSI Buy
- Analyst Count
- RYTM 13
- MKSI 10
- Target Price
- RYTM $110.38
- MKSI $128.70
- AVG Volume (30 Days)
- RYTM 589.3K
- MKSI 1.2M
- Earning Date
- RYTM 11-04-2025
- MKSI 11-05-2025
- Dividend Yield
- RYTM N/A
- MKSI 0.64%
- EPS Growth
- RYTM N/A
- MKSI 3206.74
- EPS
- RYTM N/A
- MKSI 3.95
- Revenue
- RYTM $156,287,000.00
- MKSI $3,741,000,000.00
- Revenue This Year
- RYTM $46.14
- MKSI $8.81
- Revenue Next Year
- RYTM $63.37
- MKSI $5.79
- P/E Ratio
- RYTM N/A
- MKSI $34.58
- Revenue Growth
- RYTM 53.55
- MKSI 4.50
- 52 Week Low
- RYTM $45.91
- MKSI $54.84
- 52 Week High
- RYTM $113.91
- MKSI $142.20
- Technical
- Relative Strength Index (RSI)
- RYTM 69.35
- MKSI 60.96
- Support Level
- RYTM $97.97
- MKSI $127.45
- Resistance Level
- RYTM $113.91
- MKSI $139.10
- Average True Range (ATR)
- RYTM 3.77
- MKSI 5.99
- MACD
- RYTM 1.20
- MKSI -0.35
- Stochastic Oscillator
- RYTM 79.43
- MKSI 73.59
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About MKSI MKS Instruments Inc.
MKS Inc formerly, MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others, used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue.